Ophtimalia is a young innovative company. Its mission is to design electronic medical devices in the field of ophthalmology. Using innovative solutions, those devices permit to improve the diagnosis and the treatment of ocular pathologies on humans but also on animals.
The company is strongly supported by the Vision Institute (Institut de la Vision) and is a spin-off from NXP. It was created in September 2009 and its offices are located at the Campus EffiScience in Caen.
Ophtimalia is supported by the French ministry of Research and benefits from tax refund approval for investment in R&D. This grant permits the company to be referenced as a research and development company.